Oracle Health
Raising nowOperatingORACLE HEALTH, INC.
Biotech · Safety Harbor, FL · Founded 2019
Tiny implantable cardiac device using telemedicine and AI
This company has an open fundraising round.
Financials
FY2017–FY2025 · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 1 earlier year is in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round. Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Share price over rounds
Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Cap table
Share counts as of Jun 2, 2026| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Common Stock | 17,495,815 | 1 | 100.0% | $3.11Jun 2025 |
Principal holders% as the filing states it, Jun 2, 2026
- Jaeson Bang8,500,000 Common Stock48.6%of
Sold to the crowd
- Reg CF · Jan 2020$282K
- Reg A+ · Feb 20211,667,558 Common Stock at $2.00$3.3M· 3,692 investors
- Reg CF · Mar 20231,102,384 shares at $2.95$3.3M· 2,410 investors
- Reg CF · Jun 2024$1.8M· 1,252 investors
- Reg CF · Dec 2024512,753 shares at $3.00$1.5M· 1,731 investors
- Reg A+ · Jun 20251,908,870 Common Stock at $3.11$5.9M· 2,757 investors
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
13 people
Show 4 more peopleShow fewer
Electrophysiology Cardiologist from Ohio State University. Expertise in managing cardiac arrhythmia and cardiac ablations.
Lauren serves as a Board Member for Future Cardia. Lauren is an entrepreneur and senior executive with over 25 years of experience delivering results. She is currently the CEO of Meel Corp., a producer and distributor of frozen foods to the retail, club and food service channels. Prior to Meel Corp., Lauren was the co-founder of Investran, the Private Equity industry’s leading platform for fund administration and investor reporting. She was also part of the founding team of TM1 which, through a series of M&A transactions, is now the centerpiece of IBM’s Planning and Analytics platform. Lauren is a seed investor in investment technology platforms and serves as a strategic advisor and board member to several of them.
Names and titles as disclosed on SEC Form 1-A, SEC Form C, StartEngine. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 6 of 7 annual reports (FY2019–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 77 filings on EDGAR- Form 1-SASep 24, 20260001213900-26-103009EDGAR
- Form QUALIFJun 9, 20269999999994-26-000118EDGAR
- Form 1-A POSJun 2, 20260001213900-26-063644EDGAR
- Form C-ARApr 30, 20260001213900-26-049838EDGAR
- Form 1-KApr 30, 20260001213900-26-049829EDGAR
- Form 1-SASep 29, 20250001213900-25-093039EDGAR
- Form 253G2Jun 24, 20250001213900-25-057236EDGAR
- Form QUALIFJun 23, 20259999999994-25-000114EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.